β-Like DNA polymerases and prospects for their use as targets in chemotherapy of tumors

V V Davydov1, A A Bukhvostov1, D A Kuznetsov1

  • 1Pirogov Russian National Research Medical University, Moscow, Russia.

PubMed

Insights

DNA polymerases β are crucial for DNA repair. Their altered activity in tumors promotes cancer cell survival, but targeted inhibition shows antitumor effects, suggesting new therapeutic strategies.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • DNA polymerases β (beta) are key enzymes in DNA repair.
  • Dysregulation of DNA polymerases β is observed in malignant tumor cells, impacting cell viability and proliferation.
  • Overexpression of β-like DNA polymerases supports tumor cell survival and proliferative activity.

Purpose of the Study:

  • To analyze the role of DNA polymerases β in cancer cell growth and proliferation.
  • To investigate the potential of targeting DNA polymerases β for cancer therapy.

Main Methods:

  • Comprehensive literature review of publications on DNA polymerases β structure, properties, and function in cancer.
  • Analysis of data from Russian and international databases (PubMed, Elsevier) over the past 20 years.

Main Results:

  • Overexpression of genes encoding β-like DNA polymerases is a common feature in many malignant tumors.
  • Targeted inhibition of β-like DNA polymerases demonstrates significant antiproliferative and antitumor effects.
  • Stable paramagnetic isotopes (e.g., 25Mg2+) and polydeoxyribonucleotides show promise as antitumor pharmacophores.

Conclusions:

  • Altered DNA polymerases β activity is linked to cancer cell viability and proliferation.
  • Targeting DNA polymerases β represents a viable strategy for developing novel anticancer therapies.
  • Specific isotopes and polynucleotides are potential candidates for antitumor drug development.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
Translesion DNA Polymerases02:10

Translesion DNA Polymerases

Translesion (TLS) polymerases rescue stalled DNA polymerases at sites of damaged bases by replacing the replicative polymerase and installing a nucleotide across the damaged site. Doing so, TLS allows additional time for the cell to repair the damage before resuming regular DNA replication.
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...
10.0K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K